These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19261278)

  • 1. Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome.
    Várnagy A; Bódis J; Mánfai Z; Wilhelm F; Busznyák C; Koppán M
    Fertil Steril; 2010 May; 93(7):2281-4. PubMed ID: 19261278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome.
    Lee KH; Kim SH; Jee BC; Kim YJ; Suh CS; Kim KC; Lee WD
    Fertil Steril; 2010 May; 93(7):2274-80. PubMed ID: 19249755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial.
    Palomba S; Falbo A; Carrillo L; Villani MT; Orio F; Russo T; Di Cello A; Cappiello F; Capasso S; Tolino A; Colao A; Mastrantonio P; La Sala GB; Zullo F; Cittadini E;
    Fertil Steril; 2011 Dec; 96(6):1384-1390.e4. PubMed ID: 21982727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
    Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
    Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
    Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ; Li XM; Chen XM; Zhang L
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome.
    Gera PS; Tatpati LL; Allemand MC; Wentworth MA; Coddington CC
    Fertil Steril; 2010 Jun; 94(1):173-8. PubMed ID: 19356753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
    Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P
    Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence of ovarian hyperstimulation syndrome in in-vitro-fertilization treatment over a period of 11 years].
    Niederberger V; Rottensteiner-Grohsmann C; Turnheim K; Obruca A; Brunner M; Feichtinger W
    Wien Med Wochenschr; 1995; 145(23):642-5. PubMed ID: 8578756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome.
    Mathur R; Kailasam C; Jenkins J
    Hum Fertil (Camb); 2007 Jun; 10(2):75-85. PubMed ID: 17564886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
    Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M
    Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium infusion for the prevention of ovarian hyperstimulation syndrome: a double-blind randomized controlled trial.
    El-Khayat W; Elsadek M
    Fertil Steril; 2015 Jan; 103(1):101-5. PubMed ID: 25552412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles.
    Owj M; Tehrani-Nejad ES; Amirchaghmaghi E; Baghestani AR; Ahmadi J
    Saudi Med J; 2005 Oct; 26(10):1584-7. PubMed ID: 16228060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.
    Fábregues F; Peñarrubia J; Vidal E; Casals G; Vanrell JA; Balasch J
    Fertil Steril; 2004 Oct; 82(4):827-33. PubMed ID: 15482755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of coasting on cycle outcome during in vitro fertilization/intracytoplasmic sperm injection cycles in hyper-responders.
    Kovács P; Mátyás S; Kaali SG
    Fertil Steril; 2006 Apr; 85(4):913-7. PubMed ID: 16580374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose aspirin for prophylaxis of ovarian hyperstimulation syndrome.
    Várnagy A; Koppan M; Manfai Z; Busznyak C; Bodis J
    Fertil Steril; 2008 Apr; 89(4):1035-6. PubMed ID: 18353319
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of low-dose aspirin therapy on implantation rate in women undergoing in-vitro fertilization cycles.
    Moini A; Zafarani F; Haddadian S; Ahmadi J; Honar H; Riazi K
    Saudi Med J; 2007 May; 28(5):732-6. PubMed ID: 17457441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.